Obstructive and Restrictive Pulmonary Disorders

1. Normal function first

Healthy airways are held open by a balance between smooth muscle tone, elastic recoil of the lung tissue, and the outward pull of the chest wall. During exhalation, elastic recoil passively squeezes air out; during inhalation, the diaphragm and intercostal muscles expand the chest. Compliance is how easily the lungs stretch — high compliance means easy stretching; low (reduced) compliance means stiffness. Airflow is governed by airway diameter and the pressure difference driving air movement. Pulmonary function testing (PFT) measures how much air moves (volumes and capacities) and how fast it moves (flow rates) to describe whether the problem is obstruction or restriction.

2. What changes in disease

In obstructive disease, airway narrowing from bronchospasm, mucus, inflammation, or loss of elastic support creates airflow limitation; because exhaling is impaired, air becomes trapped, progressively hyperinflating the lungs (air trapping). In asthma, reversible airway inflammation and hyperresponsiveness cause episodic bronchoconstriction. In COPD (chronic obstructive pulmonary disease), chronic irritant exposure (most often tobacco smoke) drives persistent airflow limitation. Chronic bronchitis is the airway form: mucus gland hyperplasia and inflammation narrow the bronchi and cause chronic productive cough. Emphysema is the alveolar form: destruction of alveolar walls and loss of elastic recoil collapses small airways on exhalation. Bronchiectasis (concept) is permanent, abnormal dilation of bronchi from repeated infection and inflammation that damages airway walls and impairs mucus clearance. Cystic fibrosis (concept) is a genetic disorder producing thick, sticky secretions that obstruct airways and harbor chronic infection. In restrictive disease, interstitial lung disease inflames and scars the tissue between alveoli, and pulmonary fibrosis is the fibrotic end stage, where reduced compliance stiffens the lungs so they cannot inflate fully.

3. Why the changes matter

Obstruction causes dyspnea, wheezing, prolonged expiration, cough, and eventually hypoxemia from V/Q mismatch; air trapping increases the work of breathing and flattens the diaphragm over time. Restriction causes dyspnea on exertion, rapid shallow breathing, reduced exercise tolerance, and hypoxemia as the alveolar–capillary membrane thickens. On PFTs, obstructive disease shows reduced expiratory flow (low FEV₁/FVC ratio) with preserved or increased total lung capacity, while restrictive disease shows reduced lung volumes (low FVC and TLC) with a normal or high FEV₁/FVC ratio.

How it works

1. Chronic irritant or genetic trigger sets up inflammation in airways (obstruction) or in the interstitium (restriction).
2. In obstruction, inflammation, mucus, and loss of elastic recoil narrow airways; air flows in but becomes trapped on exhalation.
3. In restriction, interstitial inflammation progresses to fibrosis, reducing compliance so the lungs cannot expand fully.
4. Gas exchange becomes impaired through V/Q mismatch (obstruction) or a thickened diffusion barrier (restriction).
5. Increased work of breathing and progressive hypoxemia drive symptoms and eventual complications.

Common confusions

Memory aids

Remember "O = Out, R = Rigid": Obstructive disease blocks getting air Out; Restrictive disease makes the lungs Rigid so air cannot get in. On PFTs, think "low ratio = obstruction; low volumes = restriction."

Quick review

Topic Recap

• Obstructive disorders limit airflow out and cause air trapping; asthma and COPD (chronic bronchitis, emphysema) are the key examples.
• Restrictive disorders reduce compliance and lung volumes; interstitial lung disease and pulmonary fibrosis are the key examples.
• PFTs separate the two: low FEV₁/FVC (obstruction) versus low TLC (restriction).
• Bronchiectasis and cystic fibrosis illustrate how impaired clearance drives chronic airway damage and infection.
• Understanding the pattern guides assessment, education, and anticipation of complications.

Knowledge Check

1. Which PFT finding best distinguishes obstructive from restrictive disease?
2. Why does emphysema cause air trapping even though the airways themselves are not necessarily narrowed by mucus?
3. A person has a normal FEV₁/FVC ratio but a reduced total lung capacity. What category of disorder does this suggest?
4. What is the pathophysiologic link between chronic inflammation and bronchiectasis?
5. How does cystic fibrosis predispose a person to both obstruction and repeated infection?

Answers and Rationales

1. Answer: The FEV₁/FVC ratio. Why: It is reduced in obstruction and normal or high in restriction, reflecting airflow versus volume limitation.
2. Answer: Destruction of alveolar walls removes elastic recoil, so small airways collapse during exhalation and trap air distally. Why: Expiration normally depends on elastic recoil to push air out.
3. Answer: Restrictive disease. Why: Restriction reduces lung volumes (low TLC) while preserving relative airflow (normal or high ratio).
4. Answer: Recurrent inflammation and infection damage airway walls and their elastic support, leading to permanent dilation and impaired mucus clearance. Why: Ongoing injury weakens the structural integrity of the bronchi.
5. Answer: Thick, sticky secretions obstruct small airways and are difficult to clear, so bacteria linger and cause chronic infection. Why: Impaired mucociliary clearance is central to cystic fibrosis lung disease.